Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New staff chief for von E

This article was originally published in The Tan Sheet

Executive Summary

Three months after moving to FDA from the American Pharmacists Association (APA) and the same week Andrew von Eschenbach is confirmed as commissioner, Susan Winckler is named acting chief of staff for the commissioner. Winckler, an attorney, joined FDA in September 2006 as policy communications director in the commissioner's Office of Policy & Planning, where she was the point person for constituent communications and policy development on issues including updating policies and operations related to the management and operation of FDA advisory committees. Starting in January 2007, Winckler will coordinate staff activities and be the principal liaison to HHS. As APA's staff counsel and VP for policy communications, she was responsible for coordinating legislative, regulatory and private sector advocacy agendas, and public relations programs (1"The Tan Sheet" Dec. 1, 2003, p. 4)...

You may also be interested in...



FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner

The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice

Push For FSA Eligibility For “Preventive” OTCs, Supplements Predicted

A wave of lobbying to expand the types of nonprescription health remedies that can be reimbursed through flexible spending accounts is on the way, American Pharmacy Association VP-Policy & Communications Susan Winckler predicted at an IIR-sponsored Rx-to-OTC switch conference in Philadelphia Nov. 20

FDA Talks Tough On Complete Response Extensions

The FDA has published fresh guidance taking a tougher stance on sponsor reasons for needing more time to respond to complete response letters.

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel